We are live on
!
Find out more
Aberdeen Group Portfolio holdings
AUM
$61.9B
1-Year Est. Return
29.81%
This Fund
S&P 500
This Quarter
Est. Return
+0.97%
1 Year Est. Return
+29.81%
3 Year Est. Return
+93.17%
5 Year Est. Return
+119.65%
10 Year Est. Return
–
AUM
$40.1B
AUM Growth
-$4.93B
(-11%)
Cap. Flow
-$4.88B
Cap. Flow
% of AUM
-12.17%
Top 10 Holdings %
Top 10 Hldgs %
19.14%
Holding
959
New
32
Increased
238
Reduced
614
Closed
39
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity National Information Services
FIS
|
+$192M |
| 2 |
FISV
Fiserv Inc
FISV
|
+$93.4M |
| 3 |
American Express
AXP
|
+$91.1M |
| 4 |
Prologis
PLD
|
+$86.5M |
| 5 |
AbbVie
ABBV
|
+$84M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo
WFC
|
+$206M |
| 2 |
Microsoft
MSFT
|
+$197M |
| 3 |
Apple
AAPL
|
+$164M |
| 4 |
RTN
Raytheon Company
RTN
|
+$154M |
| 5 |
Chevron
CVX
|
+$119M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.87% |
| 2 | Financials | 14.89% |
| 3 | Consumer Discretionary | 12.16% |
| 4 | Healthcare | 10.56% |
| 5 | Communication Services | 9.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
ArcelorMittal
MT
$49.7B
| $9.68M | 0.02% |
679,400
+191,500
| +39% | +$2.94M |
|
452
Healthpeak Properties
DOC
$15.4B
| $9.66M | 0.02% |
271,222
-25,827
| -9% | -$872K |
|
453
Ameren
AEE
$30.6B
| $9.55M | 0.02% |
119,318
-1,710
| -1% | -$131K |
|
454
Darden Restaurants
DRI
$22.3B
| $9.52M | 0.02% |
80,525
-75,139
| -48% | -$9.17M |
|
455
Microchip Technology
MCHP
$43.7B
| $9.47M | 0.02% |
203,762
-2,286
| -1% | -$104K |
|
456
Ultrapar
UGP
$6.66B
| $9.41M | 0.02% |
2,106,200
-488,102
| -19% | -$2.3M |
|
|
K
457
DELISTED
Kellanova
K
| $9.29M | 0.02% |
153,567
-3,875
| -2% | -$221K |
|
458
Regeneron Pharmaceuticals
REGN
$70.5B
| $9.28M | 0.02% |
33,462
-5,497
| -14% | -$1.63M |
|
|
PXD
459
DELISTED
Pioneer Natural Resource Co.
PXD
| $9.23M | 0.02% |
73,384
-1,201
| -2% | -$159K |
|
460
Idexx Laboratories
IDXX
$44.5B
| $9.12M | 0.02% |
33,545
-371
| -1% | -$103K |
|
461
Northern Trust
NTRS
$33.8B
| $9.12M | 0.02% |
97,759
-2,322
| -2% | -$213K |
|
462
Citizens Financial Group
CFG
$30.2B
| $9.09M | 0.02% |
256,977
-401,340
| -61% | -$14M |
|
463
Centene
CNC
$32.5B
| $9.08M | 0.02% |
209,931
-31,616
| -13% | -$1.54M |
|
464
Principal Financial Group
PFG
$24.2B
| $9.01M | 0.02% |
157,609
-3,088
| -2% | -$174K |
|
465
Jones Lang LaSalle
JLL
$15.1B
| $8.95M | 0.02% |
64,364
-94,908
| -60% | -$13.1M |
|
466
Vistra
VST
$53.3B
| $8.93M | 0.02% |
334,130
-261,143
| -44% | -$6.21M |
|
467
Blackstone Mortgage Trust
BXMT
$2.82B
| $8.93M | 0.02% |
248,984
+60,000
| +32% | +$2.13M |
|
468
Brixmor Property Group
BRX
$9.95B
| $8.91M | 0.02% |
438,991
-333
| -0.1% | -$6.26K |
|
469
Cintas
CTAS
$80.7B
| $8.9M | 0.02% |
132,740
-33,348
| -20% | -$2.13M |
|
470
Lumen
LUMN
$6.57B
| $8.87M | 0.02% |
710,214
-17,104
| -2% | -$203K |
|
471
Clorox
CLX
$11.6B
| $8.75M | 0.02% |
57,599
-2,808
| -5% | -$444K |
|
472
Fortive
FTV
$18.6B
| $8.67M | 0.02% |
200,541
-238,413
| -54% | -$11M |
|
|
NBIS
473
Nebius Group N.V.
NBIS
$46.4B
| $8.66M | 0.02% |
247,388
+1,995
| +0.8% | +$75.3K |
|
474
Rockwell Automation
ROK
$51B
| $8.63M | 0.02% |
52,396
-2,698
| -5% | -$426K |
|
475
Carnival Corporation Ltd
CCL
$35.7B
| $8.62M | 0.02% |
197,107
-3,646
| -2% | -$168K |
|
Similar funds
Aberdeen Group's Q3 2019 Portfolio in Review
As of Q3 2019, Aberdeen Group held 959 positions worth $40.1B, down 11% from $45B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Aberdeen Group withdrew a net $4.88B in Q3 2019, closing 39 positions and reducing 614 holdings. Its most notable exit was L3Harris, an estimated $88.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Aberdeen Group opened a new position in Horizon Therapeutics Public Limited Company Ordinary Shares worth $40.7M.
- Aberdeen Group's largest Q3 2019 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 1,493,397 shares worth $40.7M.
- Aberdeen Group added most to Fidelity National Information Services in Q3 2019, an estimated $192M increase.
- Aberdeen Group's biggest Q3 2019 reduction was Wells Fargo, cutting an estimated $206M.
- Aberdeen Group fully exited L3Harris in Q3 2019, selling an estimated $88.4M.
- Aberdeen Group's ten largest holdings make up 19% of its $40.1B portfolio in Q3 2019.
- Aberdeen Group opened 32 new positions and closed 39 in Q3 2019.
- Aberdeen Group's portfolio value fell 11% quarter-over-quarter to $40.1B.
Based on Aberdeen Group's 13F filing for Q3 2019, filed 13 Nov 2019.